The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study
Open accessAbstract
Background Specific immunotherapy is the only currently available allergen‐orientated treatment able to modify the natural history of respiratory allergic diseases. Safety and clinical efficacy of this treatment are well documented, but evidence about the ability to reduce new sensitizations is still poor. Objective We report a retrospective study conducted in order to assess the prevention of new sensitizations in monosensitized subjects treated with specific immunotherapy vs. monosensitized patients treated with anti‐allergic drugs. Methods 8396 monosensitized patients with respiratory symptoms were selected according to an open, retrospective design. Group A included 7182 patients submitted to specific immunotherapy (and anti‐allergic drugs when needed) for 4 years and then treated with drugs for at least 3 years. Group B included 1214 patients treated only with drugs for at least 7 years. All patients underwent prick test with a standard panel of allergens and total and specific IgE determination before and after 4 years of treatment and again 3 years later. Results Groups were well balanced. Polysensitized subjects were 23.75% in Group A and 68.03% in Group B after 4 years (P < 0.0001) and 26.95% and 76.77%, respectively, after 7 years (P < 0.0001). Asthmatic subjects were more prone to develop polysensitization in comparison to subjects suffering only from rhinitis (32.14% instead of 27.29% after 4 years, 36.5% instead of 31.33% after 7 years; P < 0.0001). Specific IgE decreased by 24.11% in Group A and increased by 23.87% in Group B (P < 0.0001). Total IgE decreased by 17.53% in Group A and increased by 13.71% in Group B (P < 0.0001). Conclusions Specific immunotherapy was observed retrospectively to reduce new sensitizations in monosensitized subjects suffering from respiratory allergic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AIT is also thought to help halt the progression of allergic disease, including prevention of new allergic sensitivities and the development of asthma.1624,1626,1678,1797,1798,1824-1826”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1626]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371
PROPHYLACTIC INOCULATION AGAINST HAY FEVER
Noon, L. (1911) · The Lancet · doi:10.1016/s0140-6736(00)78276-6 · Cited by 1,343
Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., Malefyt, R. D. W., & de Vries, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3730 · Cited by 1,101
Recombinant human interleukin 5 is a selective activator of human eosinophil function.
Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I., & Vadas, M. A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.1.219 · Cited by 949
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R. F., Malling, H., Álvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. S., Dayer, J., Durham, S. R., Demoly, P. M., et al. (1998) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 739
Prete, G. D., Maggi, E., Parronchi, P., Chrétien, I., Tiri, A., Macchia, D., Ricci, M., Banchereau, J., de Vries, J. E., & Romagnani, S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4193 · Cited by 707
Roches, A. D., Paradis, L. P., Ménardo, J.-L., Bouges, S., Daurès, J., & Bousquet, J. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70069-1 · Cited by 572
Interleukin 4 is localized to and released by human mast cells.
Bradding, P. H., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K. M., Bews, J. P. A., Hunt, T. C., Okayama, Y., & Heusser, C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1381 · Cited by 571
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.
Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D., & Umetsu, D. T. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2123 · Cited by 539
von Mutius, E., Fritzsch, C., Weiland, S. K., Röll, G., & MAGNUSSEN, H. (1992) · BMJ · doi:10.1136/bmj.305.6866.1395 · Cited by 503
Research works printed but not linked: 4
- Jacobsen L, 1995, Proceedings of the XVI European Congress of Allergology and Clinical Immunology., 145
- D'Amato G, 1991, Variazioni antigeniche nei ceppi e nei lotti di Alternaria isolati in Ann Arbor e in Napoli, G Ital Allergol Immunol Clin, 1, 133
- Ebner C, 1997, a major grass pollen allergen, Clin Exp Allergy, 27, 1
- Des Roches A, 1995, Specific immunotherapy prevents the onset of new sensitizations in monosensitized children. [Abstract], J Allergy Clin Immunol, 95, 309
Cited by
Sorted by citations
Items 201–280 of 280
Gu, J., Liang, Z., Xu, W., Liu, T. Q., Li, Z.-R., & Qin, G. (2024) · Asia Pacific Allergy · doi:10.5415/apallergy.0000000000000141 · Cited by 3
Current Clinical Guidelines for the Management of Patients with Allergic Rhinitis
Astaf’eva, N. G., Aa, B., Vishneva, Е. A., Daykhes, N. A., Zhestkov, A. V., Ивановна, И. Н., Витальевна, К. О., Karpova, E. P., Kim, I. A., Kryukov, A. I., et al. (2024) · Педиатрическая фармакология · doi:10.15690/pf.v21i4.2774 · Cited by 3
Preventive Measures Section 1: Early Interventions
H�st, A., Boner, A. L., & Odhiambo, J. A. (2004) · KARGER eBooks · doi:10.1159/000081584 · Cited by 3
Allergen immunotherapy for allergic rhinitis
Railey, M. D., Adair, M., & Burks, A. W. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0001-2 · Cited by 3
Damask, C. C. (2017) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2017.08.012 · Cited by 3
Early Intervention is Important to Prevent Sensitization to New Allergens
Terada, T., & Kawata, R. (2018) · Medical Sciences · doi:10.3390/medsci6040114 · Cited by 3
Atopic asthma: the role of allergen-specific immunotherapy
Nenasheva, N. M. (2015) · Russian Journal of Allergy · doi:10.36691/rja391 · Cited by 3
Section 3, Component 3: Control of Environmental Factors and Comorbid Conditions that affect asthma
Program, P., & theDiagnosis, T. E. P. O. (2007) · Cited by 3
The Effect of Allergen Immunotherapy on the Development of New Sensitization in Children
Çekiç, Ş., Canıtez, Y., Çiçek, F., Ocakoğlu, G., & Sapan, N. (2021) · Turkish Archives of Pediatrics · doi:10.5152/turkarchpediatr.2021.20133 · Cited by 2
A Guide to Immunotherapy for Allergic Rhinitis
(2012) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi.51.119 · Cited by 2
Klimek, L., Brehler, R., Hamelmann, E. H., Kopp, M., Ring, J., Treudler, R., Jakob, T., Worm, M., & Pfaar, O. (2019) · Allergo Journal · doi:10.1007/s15007-019-1847-4 · Cited by 2
Immunothérapie et prévention de l’atopie
Payot, F. (2014) · Revue française d'allergologie · doi:10.1016/j.reval.2014.05.004 · Cited by 2
Update on Allergen Immunotherapy for Treatment of Allergic Diseases
Kwong, K. Y. C., & Leibel, S. A. (2013) · Advances in Pediatrics · doi:10.1016/j.yapd.2013.04.008 · Cited by 2
Allergen immunotherapy: Basic concepts
Kant, S., Hassan, G., Prakash, V., Verma, A., Saheer, S., Singh, A., Singh, A., Jena, N. N., & Wani, N. (2013) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/0972-6691.116606 · Cited by 2
Sublingual Immunotherapy in Real-Life: When and Why?
Marogna, M. (2011) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.1000107 · Cited by 2
Critical appraisal of the clinical utility of sublingual immunotherapy in allergy
Aissa, S., Jazia, R. B., Ayachi, J., Salem, C. B., Hayouni, A., Abdelghani, A., Saad, H. B., & Boussarsar, M. (2016) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2016.06.002 · Cited by 2
Spezifische Immuntherapie (Hyposensibilisierung) bei allergischer Rhinokonjunktivitis
Kleine‐Tebbe, J., Hanf, G., & Herold, D. A. (2009) · Fortschritte der praktischen Dermatologie und Venerologie · doi:10.1007/978-3-540-77148-7_23 · Cited by 2
Allergen Immunotherapy for the Prevention of Allergic Asthma
Halken, S. (2018) · Current Treatment Options in Allergy · doi:10.1007/s40521-018-0179-z · Cited by 2
Impact of allergen immunotherapy on the development of new sensitization in monosensitized patients
Karaman, S., Yavaş, H. F., Erdem, S. B., Nacaroğlu, H. T., Karkıner, C. Ş. Ü., Kanık, E. T., & Can, D. (2018) · Journal of Dr Behcet Uz Children s Hospital · doi:10.5222/buchd.2018.89266 · Cited by 2
Allergen immunotherapy: on the path to achieving immune tolerance
Pavlova, K. S., Timoshenko, D. O., Gushchin, I. S., & Kurbacheva, O. M. (2024) · Immunologiya · doi:10.33029/1816-2134-2024-45-1-82-90 · Cited by 6
Does new sensitization correlate with nasal symptoms in children with allergic rhinitis?
Kim, J. Y., Han, D. H., Kim, D., Park, S. K., & Rhee, C. (2019) · The Laryngoscope · doi:10.1002/lary.28267 · Cited by 2
Immunotherapy in the Age of Anti-IgE
Finegold, I. (2004) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:27:2:075 · Cited by 2
Is immunotherapy effective in allergic disease?
Finegold, I. (2002) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200212000-00010 · Cited by 2
Is immunotherapy justified in the treatment of respiratory allergy?
Muñoz-López, F. (2007) · Allergologia et Immunopathologia · doi:10.1157/13106773 · Cited by 2
Pradalier, A., Legallais, D., Prouzeau, S., Delmas, A., Barge, J., Hentschel, V., Regnier, P., Minvielle, C., Dufour, V., Leriche, E., et al. (2003) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(03)00204-1 · Cited by 2
Inmunoterapia con alérgenos, ¿cuándo y por qué?
Zuluaga, L. S. D., Villa, R. C., Colorado, M. N. R., & Sánchez, J. (2014) · IATREIA · doi:10.17533/udea.iatreia.17755 · Cited by 1
Ndiaye, M., Bousquet, J., Dhivert-Donnadieu, H., Godard, P., & Demoly, P. M. (2002) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(02)00156-9 · Cited by 1
Preventive aspects of specific immunotherapy.
Jacobsen, L. (2003) · PubMed · Cited by 1
Demoly, P. M. (2017) · Revue française d'allergologie · doi:10.1016/j.reval.2017.02.004 · Cited by 1
Gawlik, R., Zagórny, G., & Bożek, A. (2017) · Alergologia Polska - Polish Journal of Allergology · doi:10.1016/j.alergo.2017.05.002 · Cited by 1
Safety of ultrarush allergen subcutaneous immunotherapy in children with allergic disease
Cho, S. W., Lee, G. M., Park, J., Kwon, J. W., & Kim, J. K. (2017) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2017.5.6.336 · Cited by 1
Allergenspezifische Immuntherapie bei IgE-vermittelten Erkrankungen im Kindes- und Jugendalter
Jugendheilkunde, A. P. U. A. D. Ö. G. F. K. U., Szépfalusi, Z., Horak, F., Eiwegger, T., Horak, E., Huttegger, I., Wolf‐Abdolvahab, S., Varga, E. M., & Riedler, J. (2018) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-018-0448-8 · Cited by 1
Redmond, M. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-77485-5_5 · Cited by 1
Prevención de las enfermedades alérgicas en la infancia: entre la teoría y la realidad
(2016) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2016.277 · Cited by 1
Pediatric Allergic Rhinitis: the Stepwise Treatment Approach
Redmond, M. T., Wada, K. J., & Hauswirth, D. W. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0092-2 · Cited by 1
Optimizando el abordaje del asma bronquial
Guardia Martínez, P., Miranda Páez, A., Habernau Mena, A., Carrillo Colmenero, A. M., Escobedo Araque, C. M., Ortiz Pegalajar, M. D. C., Entrenas Costa, L. M., Entrenas Castillo, M., Fernández de Alba, I., Álvarez-Sala Caballero, P., et al. (2023) · Universidad Internacional de Andalucía eBooks · doi:10.56451/10334/7376 · Cited by 1
5.アレルギー性鼻炎(VI.アレルギー疾患治療のエンドポイント,専門医のためのアレルギー学講座)
竹内, 万. (2009) · アレルギー · doi:10.15036/arerugi.58.1467 · Cited by 1
Therapeutic Procedures of Sublingual Immunotherapy in Clinical Practice
Zwacka, G., & Markert, U. R. (2003) · KARGER eBooks · doi:10.1159/000071539 · Cited by 1
Immunologische Verlaufsparameter unter spezifischer Immuntherapie
Ott, H., Wosnitza, M., & Merk, H. F. (2008) · Der Hautarzt · doi:10.1007/s00105-008-1492-4 · Cited by 1
Bousquet, J., & Demoly, P. M. (2002) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(02)00195-8 · Cited by 1
New Insights into Allergen-Specific Immunotherapy in Rhinitis and Asthma
Passalacqua, G., & Canonica, G. W. (2009) · Springer eBooks · doi:10.1007/978-4-431-99362-9_12 · Cited by 1
Szépfalusi, Z., Gruber, S., Eiwegger, T., & Dehlink, E. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1348-7 · Cited by 1
(2006) · Allergy · doi:10.1111/j.1398-9995.2006.01219_3.x · Cited by 1
Immunotherapy of Asthma: From Basic Research to Clinical Practices
Wang, H., & Shen, H. (2012) · Advanced topics in science and technology in China · doi:10.1007/978-3-642-31609-8_13
Can We Prevent the Allergic Child from Becoming a Chronic Asthmatic Adult?
Liu, A. H. (2004) · KARGER eBooks · doi:10.1159/000077651
Imunoterapia específica em alergia respiratória
Silva, E. C. D. F. (2008)
Allergen-spezifische Immuntherapie bei Kindern und Jugendlichen
Szépfalusi, Z., Gruber, S., Eiwegger, T., & Dehlink, E. (2010) · Pädiatrie & Pädologie · doi:10.1007/s00608-010-0254-6
Pharmacotherapies Early in Life to Prevent the Atopic March
Spergel, J. M., & Warner, J. O. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420226-9.00018-8
Asthma treatment: improving efficacy. Reducing costs
Muñoz-López, F. (2001) · Allergologia et Immunopathologia · doi:10.1016/s0301-0546(01)79062-3
Kleine‐Tebbe, J., Hanf, G., & Herold, D. A. (2009) · Journal of Consumer Protection and Food Safety · doi:10.1007/s00003-009-0512-3
Tratamiento del asma: mejorar la eficacia. disminuir los gastos
Muñoz-López, F. (2001) · Allergologia et Immunopathologia · doi:10.1016/s0301-0546(01)79063-5
Slowing Progression Along the Allergic Disease Continuum: Quo Vadit Immunotherapy?
Russo, C., Basile, E., Falsaperla, R., & Polosa, R. (2009) · Pediatric Asthma Allergy & Immunology · doi:10.1089/pai.2009.0019
Immunothérapie spécifique : acquis et avenir
Just, J., Goudard, E., & Grimfeld, A. (2004) · Archives de Pédiatrie · doi:10.1016/s0929-693x(04)90004-8
Modifying the allergic response in asthma*
Kim, H. L. (2007) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.3821/1913-701x(2008)140[s11:mtaria]2.0.co;2
Immunothérapie dans l’asthme de l’enfant
Just, J., Goudard, E., & Grimfeld, A. (2003) · Journal de Pédiatrie et de Puériculture · doi:10.1016/s0987-7983(03)00019-7
Early peanut exposure: poison or panacea?
Minshall, E. M., & Warner, J. O. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114509993813
Guideline on allergen-specic immunotherapy in IgE-mediated allergic diseases
Fa, O. L. I. V. E. R. P., & Johannes Gutenberg-University (2014)
EFFECTS OF ALLERGEN SPECIFIC IMMUNOTHERAPY ON THE ALLERGENS EXCLUDED FROM THE TREATMENT
Öztürk, S., Çalışkaner, Z., Güleç, M., Erel, F., Kartal, Ö., Karaayvaz, M., & Kutlu, A. (2008) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82613
Praktische Aspekte der subkutanen Immuntherapie
Kopp, M. (2009) · Kinder- und Jugendmedizin · doi:10.1055/s-0038-1629026
Árangur afnæmismeðferðar á Íslandi 1977-2006
Ríkarðsson, S. G., Löve, Y. B., Jörgensen, G. H., Gíslason, D., Ludviksson, B. R., & Lúðvíksson, B. R. (2010) · Læknablaðið · doi:10.17992/lbl.2010.0708.306
Campos, J. J. M. (2009) · NCT Neumología y Cirugía de Tórax
Yonekura, S., Sakurai, D., Sakurai, T., Iinuma, T., Okuma, Y., Yamamoto, H., Hanazawa, T., & Okamoto, Y. (2014) · 耳鼻咽喉科免疫アレルギー · doi:10.5648/jjiao.32.197
Spezifische Immuntherapie (Hyposensibilisierung)
Kleine‐Tebbe, J. (2016) · Springer eBooks · doi:10.1007/978-3-642-37203-2_54
Nalluri, K., & Dhulipalla, S. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/2568
Joint Practice Parameters on the Management of Allergic Rhinitis
Administrator, S., Caro, R. M., Recto, M. T., Hernandez, J. G., Sumpaico, M. W., Lopa, R. A. B., Castor, M. A. R., Cabungcal, A. C. A., Leon, J. G. D., Carrillo, J. R. C., et al. (2016) · Acta Medica Philippina · doi:10.47895/amp.v50i1.874
Allergen Immunotherapy for Atopic Dermatitis
Nahm, D., Lee, K. H., & Park, C. O. (2021) · Springer eBooks · doi:10.1007/978-981-15-8159-5_18
Allergen-specific immunotherapy in children, and the perspectives of the method
Трусова, О. В., Gayduk, I. M., Коростовцев, Д. С., Гайдук, И. М., & Коростовцев, Д. С. (2009) · Russian Journal of Allergy · doi:10.36691/rja1064
Asthma induced by physical effort - the problem of a large sports and not only
Glushkova, E. F., Николаевна, С. Т., Shartanova, N. V., & Krasnova, J. N. (2016) · Russian Journal of Allergy · doi:10.36691/rja350
CHAPTER 6: IMPACT OF SUBLINGUAL IMMUNOTHERAPY ON THE NATURAL HISTORY OF RESPIRATORY ALLERGY
&NA; (2009) · World Allergy Organization Journal · doi:10.1097/01.wox.0000365040.02036.63
Rondón, C., Eguíluz‐Gracia, I., Bogas, G., Barrionuevo, E., Salas, M. L., Torres, M. J., & Campo, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-75370-6_5
InmunoterapiaVacunas para las enfermedades alérgicas
Finegold, I. (2007) · Elsevier eBooks · doi:10.1016/b978-848174943-4.50022-3
CHAPTER 2: ALLERGEN SPECIFIC IMMUNOTHERAPY
&NA; (2009) · World Allergy Organization Journal · doi:10.1097/01.wox.0000365044.24907.e9
(2005) · PubMed Central
Pediatric allergy: a common occurrence with multifarious implications
Shinde, M., Chaudhary, S. M., Patil, S., Jagtap, C., Kunte, S. S., & Patel, A. (2022) · International Journal of Dental Research · doi:10.14419/ijdr.v9i1.31927
¿Cuál es el papel de la inmunoterapia en el tratamiento del asma?
Villar, M. A. (2023) · Universidad Internacional de Andalucía eBooks · doi:10.56451/10334/7386
Vaccination contre les allergies : immunothérapie spécifique des allergènes
Magnan, A. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.05.007
Saied, E. A., Shehta, M., Badawy, A. Y., & Abdelwahab, H. W. (2026) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ecdt.ecdt_90_25
SCIT Vial Preparation and Dosing
Villwock, J. A., & Ryan, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-93455-1_18
Nilsson, T. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Metadata
- Authors
- Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., & Ricciardi, L.
- Affiliations
- University of Messina (IT)
- ALK-Abelló (Italy) (IT)
- Corresponding author
- Gangemi, S.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2001-08
- Volume
- 31
- Issue
- 8
- Pages
- 1295-1302
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2085196853
- Cited by
- 281
- References
- 76
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 16 · 2015: 14 · 2014: 17 · 2013: 9 · 2012: 14
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical & Experimental Allergy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, polysensitization, allergic respiratory diseases, asthma, allergic rhinitis, antiallergic drugs, specific IgE, total IgE, allergen sensitization
- MeSH terms
- Contraindications, Administration, Inhalation, Administration, Oral, Adult, Allergens, Epitopes, Asthma, Desensitization, Immunologic, Drug Administration Schedule, Female, Follow-Up Studies, Histamine H1 Antagonists, Humans, Hypersensitivity, Delayed, Immunoglobulin E, Italy, Male, Retrospective Studies, Rhinitis, Receptors, Adrenergic, beta-2, Anti-Allergic Agents, Adrenergic beta-2 Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
